Showing results (1831-1840 of 5,935) with videos related to

Sort By:
Pageof 594
The Prostate|August 1, 1997
Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancerY Kawana, A Komiya, T Ueda, et al.
The Prostate|August 1, 1997
Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993C Mettlin
The Prostate|October 8, 1997
Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort studyK S Pawlish, D Schottenfeld, R Severson, et al.
The Prostate|October 8, 1997
Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twinsA W Meikle, R A Stephenson, C M Lewis, et al.
The Prostate|October 8, 1997
Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferationR N Skryma, N B Prevarskaya, L Dufy-Barbe, et al.
The Prostate|October 8, 1997
Angiogenic factors expressed by human prostatic cell lines: effect on endothelial cell growth in vitroP J Hepburn, K Griffiths, M E Harper
The Prostate|October 8, 1997
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostateK T Perry, C T Anthony, M S Steiner
The Prostate|March 11, 1998
Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less molluscT Turner, W H Jackson, G R Pettit, et al.
The Prostate|March 11, 1998
Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stromaS H Lang, N W Clarke, N J George, et al.
The Prostate|March 11, 1998
Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancerS S Kadkol, J R Brody, J I Epstein, et al.
Pageof 594